Malignant Neoplasms of Digestive Organs: Clinical Trials

1 trial for Malignant Neoplasms of Digestive Organs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Malignant Neoplasms of Digestive Organs: new trials by email Literature Review of Malignant Neoplasms of Digestive Organs trials Research Report on Malignant Neoplasms of Digestive Organs

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
Durvalumab, Trametinib - Malignant Neoplasms of Digestive Organs, Colorectal Cancer
Phase 2CompletedM.D. Anderson Cancer Center292018-03-212023-06-15

Narrower conditions

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

durvalumab (1)  ·  trametinib (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Michael Overman, MD (1)

Results publications

PMID 36007963